GLP-1RAs May Not Increase Breast Neoplasm Risk in Obesity and Diabetes
Risk of cancer is a major concern in the development of drugs for obesity and diabetes. In this fstudy, Brazilian researchers presenting at the annual meeting of the Endocrine Society in March, presented the results of a study that examined whether patients treated with GLP-1RAsad. a higher of breast neoplasms.